India to Australia: Exemestane Export Trade Route
India has recorded 13 verified shipments of Exemestane exported to Australia, representing a combined trade value of $224.2K USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $17.2K USD. The leading Indian exporter is INTAS PHARMACEUTICALS LIMITED, which accounts for 65% of total export value with 4 shipments worth $146.7K USD. On the buying side, GENERIC HEALTH PTY LTD is the largest importer in Australia with $77.2K USD in purchases. The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED , MAXWELL ENTERPRISES — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Australia Exemestane corridor is one of India's established pharmaceutical export routes, with 13 shipments documented worth a combined $224.2K USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 65% of all export value, reflecting the consolidated nature of India's exemestane manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $17.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (60%) and air (40%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April-June, with an average transit time of 14 days port-to-port. The route has recorded an annual growth rate of 17.0%, placing it at rank #5 among India's top exemestane export destinations globally.
On the import side, key buyers of Indian exemestane in Australia include GENERIC HEALTH PTY LTD , GENERIC HEALTH PTY LIMITED, TO THE ORDER and 8 others. GENERIC HEALTH PTY LTD is the single largest importer with 1 shipments valued at $77.2K USD.
